Efficacy of lithium vs. valproate in the treatment of mania in the elderly: A retrospective study

Stephen T. Chen, Lori L. Altshuler, Kristen A. Melnyk, Stephen M. Erhart, Elizabeth Miller, Jim Mintz

Research output: Contribution to journalArticle

65 Citations (Scopus)

Abstract

Background: This retrospective study was conducted to assess the efficacy of lithium and valproate and associated serum levels in the treatment of mania in elderly patients. Method: Records of 59 patients aged 55 years and older with minimal or no neurologic impairment, hospitalized for mania, and discharged on lithium (N = 30) or valproate (N = 29) therapy were reviewed. Data on mood stabilizer choice, serum levels, and type of mania were recorded. A clinician blinded to medications rated improvement in each case with Clinical Global Impressions (CGI) scores based on abstracted notes. Results: Overall, the percentage of patients improved was significantly greater in the lithium group than in the valproate group (67% vs. 38%, χ2 = 4.88, p = .027). Patients taking lithium with serum levels ≥ 0.8 mmol/L were more improved at discharge than those outside this range (≥ 0.8, CGI 2.0 ± 0.6 vs. < 0.8, CGI 2.6 ± 0.8, t = 2.15, p = .043). Patients taking valproate with serum levels between 65-90 μg/mL were more improved at discharge than those outside this range (65-90, CGI 2.1 ± 0.6 vs. < 65, > 90, CGI 3.3 ± 0.8, t = 3.73, p=.002). When response rates among only patients with these 'therapeutic' levels were assessed, they were similar for lithium (82%) and valproate (75%). The difference in efficacy between drugs was maintained in classic mania, but the 2 drug groups were similar when only mixed mania was analyzed (lithium 63% vs. valproate 67% improved). Conclusion: Results suggest that lithium may be more efficacious than valproate overall, but response rates for the 2 drugs were similar when 'therapeutic' serum levels were achieved. For lithium, levels similar to those reported for younger adults were associated with response. For valproate, a 'therapeutic window' different from that in younger adults was found. While the retrospective and naturalistic design of this study has limitations, these data may help direct further studies and treatment of mania in the elderly.

Original languageEnglish (US)
Pages (from-to)181-186
Number of pages6
JournalJournal of Clinical Psychiatry
Volume60
Issue number3
StatePublished - Mar 1999
Externally publishedYes

Fingerprint

Valproic Acid
Bipolar Disorder
Lithium
Retrospective Studies
Therapeutics
Serum
Young Adult
Pharmaceutical Preparations
Nervous System

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Clinical Psychology

Cite this

Chen, S. T., Altshuler, L. L., Melnyk, K. A., Erhart, S. M., Miller, E., & Mintz, J. (1999). Efficacy of lithium vs. valproate in the treatment of mania in the elderly: A retrospective study. Journal of Clinical Psychiatry, 60(3), 181-186.

Efficacy of lithium vs. valproate in the treatment of mania in the elderly : A retrospective study. / Chen, Stephen T.; Altshuler, Lori L.; Melnyk, Kristen A.; Erhart, Stephen M.; Miller, Elizabeth; Mintz, Jim.

In: Journal of Clinical Psychiatry, Vol. 60, No. 3, 03.1999, p. 181-186.

Research output: Contribution to journalArticle

Chen, ST, Altshuler, LL, Melnyk, KA, Erhart, SM, Miller, E & Mintz, J 1999, 'Efficacy of lithium vs. valproate in the treatment of mania in the elderly: A retrospective study', Journal of Clinical Psychiatry, vol. 60, no. 3, pp. 181-186.
Chen, Stephen T. ; Altshuler, Lori L. ; Melnyk, Kristen A. ; Erhart, Stephen M. ; Miller, Elizabeth ; Mintz, Jim. / Efficacy of lithium vs. valproate in the treatment of mania in the elderly : A retrospective study. In: Journal of Clinical Psychiatry. 1999 ; Vol. 60, No. 3. pp. 181-186.
@article{0ec12e89148a46709217181c54c88cf9,
title = "Efficacy of lithium vs. valproate in the treatment of mania in the elderly: A retrospective study",
abstract = "Background: This retrospective study was conducted to assess the efficacy of lithium and valproate and associated serum levels in the treatment of mania in elderly patients. Method: Records of 59 patients aged 55 years and older with minimal or no neurologic impairment, hospitalized for mania, and discharged on lithium (N = 30) or valproate (N = 29) therapy were reviewed. Data on mood stabilizer choice, serum levels, and type of mania were recorded. A clinician blinded to medications rated improvement in each case with Clinical Global Impressions (CGI) scores based on abstracted notes. Results: Overall, the percentage of patients improved was significantly greater in the lithium group than in the valproate group (67{\%} vs. 38{\%}, χ2 = 4.88, p = .027). Patients taking lithium with serum levels ≥ 0.8 mmol/L were more improved at discharge than those outside this range (≥ 0.8, CGI 2.0 ± 0.6 vs. < 0.8, CGI 2.6 ± 0.8, t = 2.15, p = .043). Patients taking valproate with serum levels between 65-90 μg/mL were more improved at discharge than those outside this range (65-90, CGI 2.1 ± 0.6 vs. < 65, > 90, CGI 3.3 ± 0.8, t = 3.73, p=.002). When response rates among only patients with these 'therapeutic' levels were assessed, they were similar for lithium (82{\%}) and valproate (75{\%}). The difference in efficacy between drugs was maintained in classic mania, but the 2 drug groups were similar when only mixed mania was analyzed (lithium 63{\%} vs. valproate 67{\%} improved). Conclusion: Results suggest that lithium may be more efficacious than valproate overall, but response rates for the 2 drugs were similar when 'therapeutic' serum levels were achieved. For lithium, levels similar to those reported for younger adults were associated with response. For valproate, a 'therapeutic window' different from that in younger adults was found. While the retrospective and naturalistic design of this study has limitations, these data may help direct further studies and treatment of mania in the elderly.",
author = "Chen, {Stephen T.} and Altshuler, {Lori L.} and Melnyk, {Kristen A.} and Erhart, {Stephen M.} and Elizabeth Miller and Jim Mintz",
year = "1999",
month = "3",
language = "English (US)",
volume = "60",
pages = "181--186",
journal = "The Journal of clinical psychiatry",
issn = "0160-6689",
publisher = "Physicians Postgraduate Press Inc.",
number = "3",

}

TY - JOUR

T1 - Efficacy of lithium vs. valproate in the treatment of mania in the elderly

T2 - A retrospective study

AU - Chen, Stephen T.

AU - Altshuler, Lori L.

AU - Melnyk, Kristen A.

AU - Erhart, Stephen M.

AU - Miller, Elizabeth

AU - Mintz, Jim

PY - 1999/3

Y1 - 1999/3

N2 - Background: This retrospective study was conducted to assess the efficacy of lithium and valproate and associated serum levels in the treatment of mania in elderly patients. Method: Records of 59 patients aged 55 years and older with minimal or no neurologic impairment, hospitalized for mania, and discharged on lithium (N = 30) or valproate (N = 29) therapy were reviewed. Data on mood stabilizer choice, serum levels, and type of mania were recorded. A clinician blinded to medications rated improvement in each case with Clinical Global Impressions (CGI) scores based on abstracted notes. Results: Overall, the percentage of patients improved was significantly greater in the lithium group than in the valproate group (67% vs. 38%, χ2 = 4.88, p = .027). Patients taking lithium with serum levels ≥ 0.8 mmol/L were more improved at discharge than those outside this range (≥ 0.8, CGI 2.0 ± 0.6 vs. < 0.8, CGI 2.6 ± 0.8, t = 2.15, p = .043). Patients taking valproate with serum levels between 65-90 μg/mL were more improved at discharge than those outside this range (65-90, CGI 2.1 ± 0.6 vs. < 65, > 90, CGI 3.3 ± 0.8, t = 3.73, p=.002). When response rates among only patients with these 'therapeutic' levels were assessed, they were similar for lithium (82%) and valproate (75%). The difference in efficacy between drugs was maintained in classic mania, but the 2 drug groups were similar when only mixed mania was analyzed (lithium 63% vs. valproate 67% improved). Conclusion: Results suggest that lithium may be more efficacious than valproate overall, but response rates for the 2 drugs were similar when 'therapeutic' serum levels were achieved. For lithium, levels similar to those reported for younger adults were associated with response. For valproate, a 'therapeutic window' different from that in younger adults was found. While the retrospective and naturalistic design of this study has limitations, these data may help direct further studies and treatment of mania in the elderly.

AB - Background: This retrospective study was conducted to assess the efficacy of lithium and valproate and associated serum levels in the treatment of mania in elderly patients. Method: Records of 59 patients aged 55 years and older with minimal or no neurologic impairment, hospitalized for mania, and discharged on lithium (N = 30) or valproate (N = 29) therapy were reviewed. Data on mood stabilizer choice, serum levels, and type of mania were recorded. A clinician blinded to medications rated improvement in each case with Clinical Global Impressions (CGI) scores based on abstracted notes. Results: Overall, the percentage of patients improved was significantly greater in the lithium group than in the valproate group (67% vs. 38%, χ2 = 4.88, p = .027). Patients taking lithium with serum levels ≥ 0.8 mmol/L were more improved at discharge than those outside this range (≥ 0.8, CGI 2.0 ± 0.6 vs. < 0.8, CGI 2.6 ± 0.8, t = 2.15, p = .043). Patients taking valproate with serum levels between 65-90 μg/mL were more improved at discharge than those outside this range (65-90, CGI 2.1 ± 0.6 vs. < 65, > 90, CGI 3.3 ± 0.8, t = 3.73, p=.002). When response rates among only patients with these 'therapeutic' levels were assessed, they were similar for lithium (82%) and valproate (75%). The difference in efficacy between drugs was maintained in classic mania, but the 2 drug groups were similar when only mixed mania was analyzed (lithium 63% vs. valproate 67% improved). Conclusion: Results suggest that lithium may be more efficacious than valproate overall, but response rates for the 2 drugs were similar when 'therapeutic' serum levels were achieved. For lithium, levels similar to those reported for younger adults were associated with response. For valproate, a 'therapeutic window' different from that in younger adults was found. While the retrospective and naturalistic design of this study has limitations, these data may help direct further studies and treatment of mania in the elderly.

UR - http://www.scopus.com/inward/record.url?scp=0032946082&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032946082&partnerID=8YFLogxK

M3 - Article

C2 - 10192594

AN - SCOPUS:0032946082

VL - 60

SP - 181

EP - 186

JO - The Journal of clinical psychiatry

JF - The Journal of clinical psychiatry

SN - 0160-6689

IS - 3

ER -